{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:15:27Z","timestamp":1785842127708,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ygyno.2007.08.060","type":"journal-article","created":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T07:17:19Z","timestamp":1193210239000},"page":"513-517","source":"Crossref","is-referenced-by-count":62,"title":["Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma"],"prefix":"10.1016","volume":"107","author":[{"given":"Gloria S.","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia G.","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana S.","family":"Gebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J.","family":"Gunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paniti","family":"Sukumvanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Einstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2007.08.060_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0090-8258(89)80041-1","article-title":"Management of malignant, mixed mesodermal tumors of the uterus","volume":"32","author":"Podczaski","year":"1989","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.060_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/gyno.1997.4827","article-title":"Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study","volume":"67","author":"Sartori","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/gyno.2001.6307","article-title":"Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case","volume":"82","author":"Watanabe","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.08.060_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0046-8177(93)90291-N","article-title":"Carcinosarcoma (malignant mixed mullerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases","volume":"24","author":"de Brito","year":"1993","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.ygyno.2007.08.060_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/(SICI)1097-0215(19970904)72:5<821::AID-IJC19>3.0.CO;2-B","article-title":"Uterine carcinosarcoma is derived from a single stem cell: an in vitro study","volume":"72","author":"Gorai","year":"1997","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<512::AID-CNCR13>3.3.CO;2-K","article-title":"Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients","volume":"82","author":"Iwasa","year":"1998","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2007.08.060_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1525-1438.2002.01151.x","article-title":"Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas","volume":"12","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/gyno.1997.4875","article-title":"An evaluation of prognostic factors in uterine carcinosarcoma","volume":"67","author":"Nordal","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ygyno.2004.07.041","article-title":"ERBB-2 gene overexpression and amplification in uterine sarcomas","volume":"95","author":"Amant","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.060_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2005.07.124","article-title":"EGFR expression and HER2\/neu overexpression\/amplification in endometrial carcinosarcoma","volume":"100","author":"LLivasy","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.060_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2004.09.050","article-title":"COX-2, c-KIT and HER-2\/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?","volume":"96","author":"Raspollini","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.ygyno.2007.08.060_bib12","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1349-7006.2003.tb01389.x","article-title":"Different expression patterns of KIT, EGFR, and HER-2 (c-erbB-2) oncoproteins between epithelial and mesenchymal components in uterine carcinosarcoma","volume":"94","author":"Sawada","year":"2003","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.060_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/gyno.1996.0015","article-title":"The expression of epidermal growth factor receptor, HER-2\/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma","volume":"60","author":"Swisher","year":"1996","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0090-8258(03)00332-9","article-title":"A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets","volume":"90","author":"Ramondetta","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.08.060_bib15","first-page":"117","article-title":"Serum biomarkers for epithelial ovarian carcinoma","volume":"3","author":"Huang","year":"2003","journal-title":"Women\u2019s Oncol. Rev."},{"issue":"Suppl 3","key":"10.1016\/j.ygyno.2007.08.060_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.060_bib17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2005.01.2757","article-title":"Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide","volume":"24","author":"Rustin","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ygyno.2007.08.060_bib18","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0002-9378(84)90444-7","article-title":"Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix","volume":"148","author":"Niloff","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ygyno.2007.08.060_bib19","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1067\/mob.2000.106251","article-title":"Preoperative CA 125 in endometrial cancer: is it useful?","volume":"182","author":"Dotters","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.ygyno.2007.08.060_bib20","first-page":"585","article-title":"Preoperative serum CA-125 levels in treating endometrial cancer","volume":"50","author":"Powell","year":"2005","journal-title":"J Reprod Med"},{"issue":"5","key":"10.1016\/j.ygyno.2007.08.060_bib21","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1067\/mob.2003.304","article-title":"CA 125 levels in the preoperative assessment of advanced-stage uterine cancer","volume":"188","author":"Jhang","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.08.060_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0002-9378(88)90163-9","article-title":"Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma","volume":"158","author":"Patsner","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ygyno.2007.08.060_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1525-1438.1993.03040259.x","article-title":"Preoperative CA-125 levels predict poor prognostic pathologic features in early stage, FIGO grade 1 and 2 endometrial adenocarcinoma","volume":"3","author":"Rose","year":"1993","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0029-7844(97)00286-X","article-title":"Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome","volume":"90","author":"Sood","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib25","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-9378(86)90269-3","article-title":"CA 125 in gynecologic practice","volume":"155","author":"Malkasian","year":"1986","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ygyno.2007.08.060_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/0002-9378(86)90358-3","article-title":"CA 125: a useful marker in endometrial carcinoma","volume":"155","author":"Duk","year":"1986","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.08.060_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/gyno.1995.0012","article-title":"Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme","volume":"59","author":"Reddoch","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.08.060_bib28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/00006250-199102000-00024","article-title":"Serial CA 125 levels during chemotherapy for metastatic or recurrent endometrial cancer","volume":"77","author":"Fanning","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ygyno.2007.08.060_bib29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000293658","article-title":"Multiple serum markers in patients with endometrial cancer","volume":"27","author":"Panici","year":"1989","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.060_bib30","first-page":"12","article-title":"Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma","volume":"84","author":"Rose","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.1525-1438.1994.04030156.x","article-title":"CA 125 in serum and tumor from patients with uterine sarcoma","volume":"4","author":"Duk","year":"1994","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.ygyno.2007.08.060_bib32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/1097-0142(19881001)62:7<1355::AID-CNCR2820620719>3.0.CO;2-4","article-title":"Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report","volume":"62","author":"Patsner","year":"1988","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ygyno.2007.08.060_bib33","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1002\/1097-0142(19861215)58:12<2625::AID-CNCR2820581213>3.0.CO;2-A","article-title":"CA-125. Use as a tumor marker with mixed mesodermal tumors of the female genital tract","volume":"58","author":"Peters","year":"1986","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2007.08.060_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/gyno.1993.1086","article-title":"Tissue CA 125 and CA 19-9 in malignant, mixed mesodermal tumors of the uterus","volume":"49","author":"Podczaski","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2007.08.060_bib35","doi-asserted-by":"crossref","first-page":"243.e1","DOI":"10.1016\/j.ajog.2006.09.035","article-title":"Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors","volume":"196","author":"Huang","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ygyno.2007.08.060_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/gyno.2000.6001","article-title":"A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study","volume":"79","author":"Sutton","year":"2000","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807006282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825807006282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T06:29:22Z","timestamp":1546496962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825807006282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0090825807006282"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2007.08.060","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}